FDA.reportPublic FDA data

Tirosint

Product NDC
24090-499
11-digit product format
240900499
Labeler code
24090
Product ID
24090-499_a4458922-b538-42d6-b4d3-7942ee950f04
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Levothyroxine Sodium
Dosage form
CAPSULE
Route
ORAL
Labeler
Akrimax Pharmaceuticals, LLC
Application
NDA021924
Marketing category
NDA
Marketing start
2010-04-01
Marketing end
0000-00-00
Substance
LEVOTHYROXINE SODIUM
Active strength
150 ug/1
Pharmacologic classes
l-Thyroxine [EPC],Thyroxine [CS]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
24090-499-072020-09-15C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-499-842020-09-15C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-499-942020-09-15C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-499-992020-09-15C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-499-072020-01-31C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-499-842020-01-31C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-499-942020-01-31C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40
24090-499-992020-01-31C16284748780-19d75b9d0-b5e7-f424-e053-dadaa90a57cef4d851f6-6bf5-4ed5-8d3a-1646773c4d40

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
24090-499-84EA - Each24090-4992ffc9d23-e952-4a70-8597-bc6e46d9ee3312012-07-24